Verve’s Proof-Of-Concept Data Doesn’t Inspire Confidence (NASDAQ:VERV)


anatomical heart made of felt textile in red background

Carol Yepes/Moment via Getty Images

Verve’s Genetic Play: Rewriting the Script on Cholesterol

Verve Therapeutics (NASDAQ:VERV) has set out to change the way we treat cardiovascular disease.

With a myriad of safe, affordable, trusted, and effective drugs like statins, SGLT-2 inhibitors, PCSK9



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *